Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer

[1]  R. Lothe,et al.  Genome profiles of familial/bilateral and sporadic testicular germ cell tumors , 2002, Genes, chromosomes & cancer.

[2]  C. Plass,et al.  Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors , 2002, Oncogene.

[3]  Y. Yonekawa,et al.  Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene. , 2001, Carcinogenesis.

[4]  R. Lothe,et al.  Evaluation of loss of heterozygosity/allelic imbalance scoring in tumor DNA. , 2001, Cancer genetics and cytogenetics.

[5]  M. Esteller.  Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. , 2000, European journal of cancer.

[6]  Scar,et al.  Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.

[7]  L. Looijenga,et al.  Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model , 2000, British Journal of Cancer.

[8]  P. Macpherson,et al.  Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents. , 2000, Cancer research.

[9]  G. Kang,et al.  Correlation of p16 Hypermethylation with p16 Protein Loss in Sporadic Gastric Carcinomas , 2000, Laboratory Investigation.

[10]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[11]  J. Moul,et al.  Molecular Genetic Parameters in Pathogenesis and Prognosis of Testicular Germ Cell Tumors , 2000, European Urology.

[12]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[13]  L. Looijenga,et al.  A molecular model for the development of germ cell cancer , 1999, International journal of cancer.

[14]  J. Nadeau,et al.  Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain , 1999, Nature Genetics.

[15]  C. Plass,et al.  A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. , 1999, Genomics.

[16]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.

[17]  T. Brent,et al.  Methylation of selected CpGs in the human O6‐methylguanine‐DNA methyltransferase promoter region as a marker of gene silencing , 1999, Molecular carcinogenesis.

[18]  J. Moul,et al.  MOLECULAR ANALYSIS OF P16Ink4/CDKN2 AND P15Ink4B/MTS2 GENES IN PRIMARY HUMAN TESTICULAR GERM CELL TUMORS , 1998 .

[19]  R. Chaganti,et al.  A genetic perspective of male germ cell tumors. , 1998, Seminars in oncology.

[20]  T. Brent,et al.  Methylation hot spots in the 5' flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. , 1997, Cancer research.

[21]  B Johansson,et al.  Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. , 1997, Cancer research.

[22]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Kaina,et al.  Protective effect of O6‐methylguanine‐DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs , 1996, International journal of cancer.

[24]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[25]  T. Brent,et al.  Localization of methylation sites in the human O6-methylguanine-DNA methyltransferase promoter: correlation with gene suppression. , 1995, Carcinogenesis.

[26]  L. Harris,et al.  Identification of a 59 bp enhancer located at the first exon/intron boundary of the human O6-methylguanine DNA methyltransferase gene. , 1994, Nucleic acids research.

[27]  D. Carson,et al.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.

[28]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[29]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[30]  R. Lothe,et al.  Frequent loss of 11p13 and 11p15 loci in male germ cell tumours , 1993, Genes, chromosomes & cancer.

[31]  S. Fosså,et al.  Salvage treatment in male patients with germ cell tumours. , 1993, British Journal of Cancer.

[32]  H. J. Evans,et al.  Advances in Cancer Research , 1985, British Journal of Cancer.

[33]  N. B. Atkin,et al.  SPECIFIC CHROMOSOME CHANGE, i(12p), IN TESTICULAR TUMOURS? , 1982, The Lancet.

[34]  R. Lothe,et al.  Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence. , 2001, Neoplasia.

[35]  B. Robert.  De la charte du bassin parisien vers un établissement public , 1998 .

[36]  M. Dolan,et al.  Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. , 1995, Progress in nucleic acid research and molecular biology.

[37]  D. Sleijfer,et al.  Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance. , 1989, Laboratory investigation; a journal of technical methods and pathology.